多离子治疗头癌的剂量平均 LET 升级:为前性,开放标签,单臂,单中心试验 (MULTI-ION-HN-I) 的第一阶段研究方案
Hiroaki Ikawa1, Makoto Shinoto2, Masashi Koto3
1QST Hospital, National Institutes for Quantum Science and Technology (QST), Chiba, Japan ikawa.hiroaki@qst.go.jp.
BMJ open
|October 16, 2025
概括
这项研究研究了头癌的多离子疗法,旨在增加剂量平均线性能量转移 (LETd) 以更好地控制瘤. 该研究评估了在患有晚期头恶性瘤的患者中将LETd升级到90keV/μm的安全性.
科学领域:
- 辐射瘤学 辐射瘤学
- 医学物理 医学物理
- 在瘤学瘤学.
背景情况:
- 对于不可切除的头癌 (HNC) 的标准治疗方法,如放射疗法 (RT) 和化疗放射疗法 (chemo-RT),具有局限性,特别是在抗辐射的非状细胞癌中.
- 碳离子 (C-ion) RT由于高线性能量转移 (LET) 和相对生物有效性 (RBE) 而对HNC有希望,但局部复发仍然存在.
- 为了改善局部控制,正在探索升级剂量平均LET (LETd),多离子疗法可以实现比单独C离子疗法更高的LETd.
研究的目的:
- 为了评估安全性,并确定在患有不可手术的头恶性瘤的患者中使用多离子疗法升级剂量平均的LETd (LETd) 的最大耐受度.
- 评估通过多离子疗法将LETd从70keV/μm提高到90keV/μm的安全性,用于治疗头癌.
主要方法:
- 一项非随机的,开放的,第一阶段研究,招募了多达18名头恶性瘤患者.
- 患者接受多离子疗法 (,碳,氧或离子),用RBE加权剂量从57.6至70.4Gy分为16个小部分,持续4周.
- 从70 keV/μm以10 keV/μm的增量升级至90 keV/μm,并通过剂量限制性毒性评估安全性,辐射后长达90天.
主要成果:
- 这项研究旨在评估在接受多离子治疗的头癌患者中升级LETd的安全性.
- 主要终点是增加LETd到瘤的安全性和耐受性.
- 其次要目标包括在测试范围内确定最大可容忍的LETd.
结论:
- 多离子疗法为头癌提供了一种超越传统碳离子疗法升级LETd的策略.
- 这种方法旨在通过提高辐射输送的生物有效性来增强瘤控制.
- 进一步的研究将确定这种先进的辐射方式的安全概况和最佳LETd.
相关概念视频
Bioavailability Study Design: Single Versus Multiple Dose Studies
205
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
205
Dosage Regimen: Multiple Oral Dosage
226
Understanding how a drug's concentration fluctuates within the body over time is crucial in pharmacokinetics, particularly with multiple oral doses. A graphical representation of multiple oral dosages provides insight into these dynamics. Typical accumulation curves of a drug's concentration in the body reveal a sawtooth pattern, indicating periodic peaks and troughs correlating with each dose administration and the drug's subsequent elimination.The plasma concentration at any time during an...
226
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
218
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
218
Dosage Regimen: Fixed Dose
2.3K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
2.3K
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
232
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
232
Dose Size and Dosing Frequency: Determination Methods
274
Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...
274


